Apr 21, 2017 - Having secured approval for the first lookalike competitor to Glaxosmithkline's (NYSE:GSK) Advair, Teva's (NYSE:TEVA) strategy is to launch it in the way it knows best: as a generic. In announcing US
Apr 21, 2017 - Written by Bob Ciura for Sure Dividend on April 19th, 2017. Investors can count on the health care sector for dividends. Pfizer (NYSE:PFE) and Teva Pharmaceuticals (NYSE:TEVA) have dividend yields of
Apr 20, 2017 - Penn Davis Mcfarland Inc Buys Celgene, Bristol-Myers Squibb Company, Sells Teva Pharmaceutical Industries, Skechers USA, Chevron, Stocks: CELG,BMY,TEVA,SKX,CVX,FIT,HCP,, release date:Apr 20, 2017
Apr 20, 2017 - Teva Pharmaceutical Industries (TEVA +0.3%) announces the simultaneous U.S. launch of AirDuo RespiClick (fluticasone propionate and salmeterol) and its authorized generic for the treatment of asthma p
Apr 18, 2017 - Post-election, hopes surged that there would be an increase in M&A activity in the pharma and biotech sector in 2017.
Apr 13, 2017 - Shares of Neurocrine Biosciences, Inc. (NBIX) soared 25% on Tuesday after announcing the FDA approval ofIngrezza (valbenazine) capsules a day before for the treatment of adults with tardive dyskinesia (TD).
Apr 13, 2017 - Teva Pharmaceutical industries (TEVA -0.4%) reports that it received a Warning Letter from the FDA on April 10 related to violations observed during an on-site inspection at its plant in China, specif
Apr 04, 2017 - Teva (NYSE:TEVA) managed to deliver investors some badly needed good news last night, in the shape of US approval for its Huntington’s treatment Austedo. After last year’s complete response letter the
Mar 28, 2017 - Allergan plc (AGN) in collaboration with Paratek Pharmaceuticals, Inc. (PRTK) has announced positive results from two phase III studies on sarecycline
Mar 27, 2017 - Risk-Reward With Teva Pharmaceutical, Stocks: AGN,TEVA, David Tepper, release date:Mar 27, 2017